Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1986
A subchronic, teratologic, and dominant lethal study of 2-methylresorcinol in rats. I. Subchronic toxicityT A Re, R F Loehr, S C Rodriguez, et al.Journal of Environmental Pathology and Toxicology|May 1, 1978
Testicular atrophy and impaired spermatogenesis in rats fed high levels of the methylxanthines caffeine, theobromine, or theophyllineM A Weinberger, L Friedman, T M Farber, et al.Journal of Environmental Pathology and Toxicology|January 1, 1979
Testicular atrophy and impaired spermatogenesis in rats fed high levels of the methylxanthines caffeine, theobromine, or theophyllineL Friedman, M A Weinberger, T M Farber, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 2, 1998
An open-label dose comparison study of ondansetron for the prevention of emesis associated with chemotherapy prior to bone marrow transplantationC L Osowski, S P Dix, M Lynn, et al.The Annals of Pharmacotherapy|February 24, 2001
Practice guidelines for lipid-based amphotericin B in stem cell transplant recipientsR E Quilitz, A D Arnold, G R Briones, et al.Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive careH K Holland, S P Dix, R B Geller, et al.Bone Marrow Transplantation|August 1, 1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiationR B Geller, S M Devine, K O'Toole, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxisS M Devine, R B Geller, L B Lin, et al.Pageof 2